January Salas-McKee

University of Pennsylvania — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

5h-index1.7kcitations22works0.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(19), CAR-T cell therapy research(16), Advanced biosensing and bioanalysis techniques(6), Viral Infectious Diseases and Gene Expression in Insects(4), RNA Interference and Gene Delivery(2)

Publications22 total

Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Tables from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 2 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Tables from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 2 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
Cancer Immunology Research·2024· 2 cited
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
Immunity·2023· 151 citedOpen Access
G-CSF Mobilized Apheresis As an Alternative Source of CAR T-Cells
Blood·2022· 1 cited
Characterization of autologous T cells engineered to express NY-ESO-1 TCR with multiplexed CRISPR/Cas9 editing (NYCE T Cells)
Cytotherapy·2020· 2 cited
Pre-clinical development of multiplex-CRISPR-edited cell and gene therapy products
Cytotherapy·2020
CRISPR-engineered T cells in patients with refractory cancer
Science·2020· 1.4k citedOpen Access
First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to Eliminate Endogenous TCR and PD-1 (NYCE T cells) in Advanced Multiple Myeloma (MM) and Sarcoma
Blood·2019· 14 cited
Optimization of CRISPR-Cas9 knock-out of CD33 in human hematopoietic stem / progenitor cells for allogeneic transplantation in patients with acute myeloid leukemia
Cytotherapy·2019· 4 cited
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
Human Vaccines & Immunotherapeutics·2019· 67 citedOpen Access
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Genome biology·2019· 79 citedOpen Access
Additional file 1: of iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Figshare·2019Open Access
Additional file 2: of iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Figshare·2019Open Access
page 1 of 2Next →

Frequent Co-authors

Carl H. June(19), Joseph A. Fraietta(14), Julie K. Jadlowsky(13), Saar Gill(11), Megan M. Davis(10), Sangya Agarwal(10), Ju-Fang Chang(9), Nils Wellhausen(9), Nils W. Engel(9), Jack H. Landmann(9), Caitlin R. Hopkins(9), Adham S. Bear(9), Mehmet Emrah Selli(9), Gerald P. Linette(9), Nathan Singh(9), Christopher L. Nobles(8), Frederic D. Bushman(8), J. Joseph Melenhorst(7), Yangbing Zhao(7), Gabriela Plesa(5)